This inventor holds 5 USPTO granted patents. Top assignees: Institut Pasteur, Université Pierre Et Marie Curie (Paris 6). Active years: 1996-2012.
Company Filing History:
4 out of 897 
1 out of 158 
Years Active: 1996-2012
Title: Gordon Langsley: Innovator in Peptide Research
Introduction
Gordon Langsley is a notable inventor based in Paris, France. He has made significant contributions to the field of peptide research, particularly in the development of novel synthetic and natural peptides. With a total of 5 patents, his work focuses on innovative solutions for treating viral and parasitic infections, as well as tumors.
Latest Patents
One of Langsley's latest patents is titled "Synthetic or natural peptides binding protein phosphatase 2A, identification method and uses." This invention relates to novel peptides that are less than 30 amino acids in size, specifically designed to bind to a type 2A protein phosphatase holoenzyme or one of its subunits. The peptides are intended for use in treating various infections and tumors. Another significant patent involves molecules containing at least one peptide sequence, which further expands the potential applications of his research.
Career Highlights
Throughout his career, Langsley has worked with prestigious institutions such as Institut Pasteur and Université Pierre et Marie Curie (Paris 6). His research has been instrumental in advancing the understanding of peptide interactions and their therapeutic potential.
Collaborations
Langsley has collaborated with esteemed colleagues, including Pierre Druilhe and Odile Puijalon-Mercereau. These partnerships have enriched his research and contributed to the success of his innovative projects.
Conclusion
Gordon Langsley's work in peptide research exemplifies the impact of innovation in the medical field. His patents and collaborations highlight his commitment to advancing therapeutic solutions for complex health challenges.